• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aratana Therapeutics Inc

+ Add to Watchlist

PETX:US

16.4300 USD 3.3600 25.71%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Aratana Therapeutics Inc (PETX)

Open: 15.7700 Day's Range: 14.7700 - 16.5800 Volume: 2,907,075
Previous Close: 13.0700 52wk Range: 9.2000 - 25.5000 1-Yr Rtn: +2.75%

Stock Chart for PETX

No chart data available.
  • PETX:US 16.4900
  • 1D
  • 1M
  • 1Y
13.0700
Interactive PETX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PETX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6226
Est. EPS (USD) (12/2014) -1.4000
Est. PEG Ratio -
Market Cap (M USD) 570.21
Shares Outstanding (M) 34.71
30 Day Average Volume 317,960
Price/Book (mrq) 2.8990
Price/Sale (ttm) 677.7923
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PETX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PETX

Aratana Therapeutics, Inc. develops biomedical therapeutics for animals. The Company offers products to treat the pain and inflammation associated with osteoarthritis in pets. Aratana Therapeutics markets its products in the United States.

Steven St PeterPresident/CEO/Co-FounderCraig A ToomanCFO/Treasurer
Ernst HeinenChief Development OfficerLinda RhodesChief Scientific Officer
More Company Profile & Key Executives for PETX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil